Earnings Feed
Start Free
|4Feb 16, 5:03 PM ET

GENEREX BIOTECHNOLOGY CORP 4

4 · GENEREX BIOTECHNOLOGY CORP · Filed Feb 16, 2016

Insider Transaction Report

Form 4
Period: 2016-02-16
GENEREX BIOTECHNOLOGY CORPGNBT
Brusegard David
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2016-02-16$0.00/sh+1,667,671$1,668→ 5,615,070 total
  • Exercise/Conversion

    Common Stock Purchase Option

    2016-02-16−1,667,671→ 0 total
    Exercise: $0.00From: 2016-02-09Exp: 2020-10-26→ Common Stock (1,667,671 underlying)

Documents

1 file
  • 4
    brusegard021616form4.xmlPrimary

    FORM 4